For the first time in India ,German Remedies, a part of the Zydus group, has launched Fludara Oral (fludarabine) for the treatment of chronic lymphocytic leukemia. Chronic Lymphocytic Leukemia (CLL) is a cancer of the lymphocytes. It is a serious, progressive disease, which at present has no cure. The disease is unknown in childhood, very uncommon in young people and becomes progressively more common with increasing age.
Fludarabine has emerged as one of the leading drugs for treatment of CLL, and can be used as a stand -alone therapy or as a combination therapy. It helps control CLL by shortening the life-span of existing leukemia cells and interferes with the making of new DNA, thus preventing leukemia cells from growing. With this treatment the remission can last for several years, thereby increasing the span of survival.
Executive director of German Remedies has been cited as saying that their main goal is to improve the quality of life for the patients and enable better disease management especially in the field of Oncology, their company's core therapy area., Chronic lymphocytic leukemia, India, German remedies, zydus, patients, fludara oral, fludarbine, CLL, lymphocytes, cancer, disease, therapy, leukemia cells, DNA, oncology.